Related Subjects:
|Respiratory Failure
|Non invasive ventilation (NIV)
|Intubation and Mechanical Ventilation
|Critical illness neuromuscular weakness
|Haemodialysis
|Dobutamine
โ ๏ธ Etomidate is an IV anaesthetic agent withdrawn for continuous ICU sedation because of
increased mortality due to adrenocortical suppression (inhibition of 11ฮฒ-hydroxylase).
Still used for induction of anaesthesia, particularly in haemodynamically unstable patients.
Always check the BNF link here.
๐ About
- Carboxylated imidazole compound (introduced 1972, Europe).
- IV anaesthetic & induction agent.
- Favoured in cardiovascularly unstable patients due to minimal effect on BP/HR.
โ๏ธ Mode of Action
- Short-acting IV anaesthetic.
- Inhibits 11ฮฒ-hydroxylase (CYP11B1) โ โ cortisol synthesis โ adrenal suppression.
- At high concentrations also inhibits cytochrome P450 enzymes.
๐ Indications & Dose
- Adults: 0.15โ0.3 mg/kg IV over 30โ60 seconds.
- Elderly: 0.15โ0.2 mg/kg IV over 30โ60 seconds.
- Onset: 5โ15 seconds. Recovery: 5โ15 minutes.
- Max per dose: 60 mg.
๐ Interactions
โ ๏ธ Cautions
- Shock, adrenal insufficiency, acute porphyria.
- Cardiovascular disease, fixed cardiac output, hypovolaemia.
- Elderly patients (increased sensitivity).
๐ซ Contraindications
โ Side Effects
- Apnoea, hypotension, nausea, skin reactions.
- Involuntary muscle movements (myoclonus).
- Adrenocortical suppression (clinically significant with prolonged infusion).
- โ intracranial pressure, โ cerebral blood flow, โ cerebral oxygen demand.
๐ References